ITGAX and neoplasm: On this day 7.5 × 105 LL-37-DC or control DC, sorted on the basis of CD11c and MHC II expression, activated with poly I:C and Pam3Csk4 and exposed to sonicated tumor cell antigen, were injected subcutaneously.